Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03135210
Other study ID # 1703M10081
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 13, 2017
Est. completion date February 1, 2020

Study information

Verified date February 2021
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients undergoing extracorporeal membrane oxygenation (ECMO) are at high risk for deconditioning and functional decline. The primary aim of this study is to assess the functional impact of leg exercise during the pre-ambulation phase in patients undergoing ECMO.


Description:

The investigators are conducting this study to explore the impact of closed-chain leg exercise in individuals undergoing ECMO. Aim 1: To determine if closed-chain leg exercise decreases the time to initial ambulation. The investgators hypothesize that adding leg exercise will decrease time to ambulation. Aim 2: To determine the impact of closed chain leg exercise on functional ability. The investigators hypothesize that adding leg exercise will improve functional outcomes when added to an existing early mobilization program. Aim 3: To determine the effect of closed chain leg exercise on hospital outcomes. The investigators hypothesize that hospital related outcomes will improve when leg exercise is added to an existing early mobilization program.


Recruitment information / eligibility

Status Completed
Enrollment 4
Est. completion date February 1, 2020
Est. primary completion date February 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Patients with refractory respiratory failure undergoing ECMO at the University of Minnesota Medical Center, Fairview. - Able to follow 3 out of 3 one-step commands via protocol. - Active Inpatient Physical Therapy Referral. - ECMO delivery is veno-venous with internal jugular catheter. Exclusion Criteria: - Femoral catheter of any kind present - Veno-arterial ECMO set-up - Sedation such that self-consent is not attainable - Medical instability, as determined by primary critical care physician

Study Design


Intervention

Other:
Open-Chain Leg Exercise
Individuals in the open-chain group will progress through standard mobility progression.
Device:
Closed-Chain Leg Exercise
Individuals in the closed-chain group will progress through standard mobility exercises with the addition of closed-chain leg exercises using the MOVEO platform.

Locations

Country Name City State
United States University of Minnesota Medical Center, Fairview Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to Ambulation Time to ambulation is measured as the number of days required for the participant to regain the ability to walk without the need for any kind of assistance. The unit of measure is days. Baseline, to day 45 if applicable
See also
  Status Clinical Trial Phase
Completed NCT06010446 - Intravenous Continuous LMWH Seems to be Safe Alternative to UFH in VV ECMO Patients